Results 161 to 170 of about 16,216 (335)

Patients’ perspectives and preferences in the choice of inhalers: the case for Respimat® or HandiHaler®

open access: yesPatient Preference and Adherence, 2016
Pieter Nicolaas Richard Dekhuijzen,1 Federico Lavorini,2 Omar S Usmani3 1Department of Pulmonary Diseases, Radboud University Medical Center, Nijmegen, the Netherlands; 2Department of Experimental and Clinical Medicine, Careggi University Hospital ...
Dekhuijzen PNR, Lavorini F, Usmani OS
doaj  

Clinical recommendations for dry powder inhaler use in the management of COPD in primary care. [PDF]

open access: yesNPJ Prim Care Respir Med, 2022
Leving MT   +23 more
europepmc   +1 more source

Recent advances of non‐invasive sensors for smart wearable respiratory monitoring

open access: yesVIEW, EarlyView.
Respiration contains rich physiological and pathological information, making it one of the most fundamental and continuous vital signs. Respiration monitoring is a non‐invasive and simple, but incredibly powerful, tool for assessing health, managing disease, and tracking fitness.
Jianhui Chen   +8 more
wiley   +1 more source

Toronto's drug policy paradox: Harm reduction sites and drug police occurrences in Toronto neighborhoods (1992–2020)

open access: yesCriminology, EarlyView.
Abstract Discourse around drug policy presents a stark contrast between policing and harm reduction models, sparking debates on the state's regulatory versus protective role. Canada is an ideal case to study drug policy models due to its global recognition as a leader in harm reduction alongside continued reliance on policing of drugs.
Taylor Domingos
wiley   +1 more source

Effectiveness of inhaler types for real-world asthma management: retrospective observational study using the GPRD

open access: yesJournal of Asthma and Allergy, 2011
David Price1,2 John Haughney1, Erika Sims2, Muzammil Ali2, Julie von Ziegenweidt2, Elizabeth V Hillyer2, Amanda J Lee3, Alison Chisholm2, Neil Barnes41Centre of Academic Primary Care, University of Aberdeen, Aberdeen, UK; 2Research in Real Life Ltd ...
Price D   +8 more
doaj  

<p>Randomized dose-finding study of batefenterol via dry powder inhaler in patients with COPD</p>

open access: gold, 2019
Courtney Crim   +10 more
openalex   +2 more sources

5‐Methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT) for alcohol use disorder: An open‐label, phase 2, proof‐of‐concept, clinical trial

open access: yesAddiction, EarlyView.
Abstract Background and Aims Psychedelic drugs may help treat alcohol use disorder (AUD). This study evaluated BPL‐003, a novel intranasal powder formulation of 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT) benzoate salt, in people with moderate–severe AUD enrolled in a standard of care, 10‐week programme of relapse‐prevention oriented Cognitive ...
John Marsden   +10 more
wiley   +1 more source

Soft mist, dry powder, and smart inhalers: comparative technologies and clinical impact on asthma and COPD management

open access: yesThe Egyptian Journal of Bronchology
Asthma and chronic obstructive pulmonary disease (COPD) continue to pose significant global health burdens, with optimal inhalation therapy being central to effective disease control.
Selvakumar Muruganantham   +1 more
doaj   +1 more source

Home - About - Disclaimer - Privacy